Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
546
-
Total 13F shares, excl. options
-
73,533,826
-
Shares change
-
+1,097,636
-
Total reported value, excl. options
-
$29,548,540,482
-
Value change
-
+$474,492,825
-
Put/Call ratio
-
113%
-
Number of buys
-
240
-
Number of sells
-
-256
-
Price
-
$402.02
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2016
643 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2016.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 546 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,533,826 shares
of 104,986,330 outstanding shares and own 70.04% of the company stock.
Largest 10 shareholders include FMR LLC (9,134,350 shares), Capital World Investors (7,810,538 shares), WELLINGTON MANAGEMENT GROUP LLP (6,958,832 shares), VANGUARD GROUP INC (4,811,431 shares), STATE STREET CORP (3,171,874 shares), SANDS CAPITAL MANAGEMENT, LLC (2,497,378 shares), BlackRock Fund Advisors (2,290,395 shares), JENNISON ASSOCIATES LLC (2,122,148 shares), BlackRock Institutional Trust Company, N.A. (2,017,842 shares), and Artisan Partners Limited Partnership (1,772,702 shares).
This table shows the top 546 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.